Latest Breaking News On - Grand pharmaceutical group limited - Page 1 : comparemela.com

Telix reports fourth consecutive quarter of positive operating cash flow

/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying.

United statesUnited kingdomNew zealandChristian behrenbruchCdx illuccix clinicaltrialsPrnewswire telixKyahn williamsonMerck kgaEuropean unionAustralian securities exchangeTelix pharmaceuticalsAccess programDrug administrationMerck kgaaAustralian therapeutic goods administrationParty transactions

Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company

/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the half-year ended 30 June 2023. All.

United statesUnited kingdomBruxelles capitaleDedicaid gmbChristian behrenbruchKyahn williamsonTelix pharmaceuticalsDrug administrationAustralian therapeutic goods administrationEuropean unionPrnewswire telix pharmaceuticals limitedAustralian securities exchangeHealth canadaTelix manufacturing solutionsPharmaceuticals limitedGrand pharmaceutical group limited

Telix Pharmaceuticals Limited: First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients

Telix Pharmaceuticals Limited: First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCdx illuccixKyahn williamsonTelix asia pacificTelix pharmaceuticalsEuropean unionDrug administrationTelix pharmaceuticals limited disclosure committeeHealth canadaCorporate communicationsAustralian securities exchangeZhongnan hospital of wuhan universityGroup limited grand pharmaAustralian therapeutic goods administrationPrnewswire telix pharmaceuticals limited

First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients

First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomYong heKyahn williamsonCdx illuccixTelix asia pacificPrnewswire telix pharmaceuticals limitedTelix pharmaceuticalsGroup limited grand pharmaAustralian securities exchangeCorporate communicationsAustralian therapeutic goods administrationZhongnan hospital of wuhan universityHealth canadaEuropean unionTelix pharmaceuticals limited disclosure committee

First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix) for Prostate Cancer Imaging in Chinese Patients

First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix) for Prostate Cancer Imaging in Chinese Patients
malaysiasun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from malaysiasun.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCdx illuccixTelix asia pacificKyahn williamsonEuropean unionHealth canadaTelix pharmaceuticals limited disclosure committeeAustralian therapeutic goods administrationDrug administrationPrnewswire telix pharmaceuticals limitedCorporate communicationsGroup limited grand pharmaTelix pharmaceuticalsAustralian securities exchangeZhongnan hospital of wuhan university